Humalog and Entecavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Entecavir (entecavir). Common drug interactions include erythema multiforme among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Entecavir. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

On Jul, 30, 2026

37 people who take Humalog and Entecavir together, and have interactions are studied.

Humalog and Entecavir drug interactions.

What are the common drug interactions of Humalog and Entecavir, by gender? *:

female:

Erythema multiforme (a type of hypersensitivity reaction)
Hospitalisation
Infection
Nausea (feeling of having an urge to vomit)
Pain
Sepsis (a severe blood infection that can lead to organ failure and death)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Diarrhoea
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Oxygen saturation decreased

male:

Diarrhoea
Fatigue (feeling of tiredness)
Drug ineffective
Fall
Red blood cell count decreased
Renal failure (kidney dysfunction)
Syncope (loss of consciousness with an inability to maintain postural tone)
Blood glucose increased
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Immunodeficiency

What are the common drug interactions of Humalog and Entecavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

30-39:

n/a

40-49:

Myopathy (a muscular disease in which the muscle fibres do not function)

50-59:

Diarrhoea
Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Bone pain
C-reactive protein increased
Erythema multiforme (a type of hypersensitivity reaction)
Fatigue (feeling of tiredness)
Syncope (loss of consciousness with an inability to maintain postural tone)
Blood glucose increased
Visual impairment

60+:

Bacterial sepsis
Myelopathy (any neurologic deficit related to the spinal cord)
Sepsis (a severe blood infection that can lead to organ failure and death)
Urinary tract infection
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Immunodeficiency
Influenza
Neuropathy peripheral (surface nerve damage)
Obesity (having too much body fat)
Pain

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 13.51%
Back Pain: 4 people, 10.81%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.11%
High Blood Pressure: 3 people, 8.11%
Pain: 3 people, 8.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
Disease Complication: 3 people, 8.11%
Type 2 Diabetes: 2 people, 5.41%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 5.41%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Entecavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously